Improved Biofilm Antimicrobial Activity of Polyethylene Glycol Conjugated Tobramycin Compared to Tobramycin in Pseudomonas aeruginosa Biofilms

Molecular Pharmaceutics
Ju DuH D C Smyth

Abstract

The objective of this study was to develop a functionally enhanced antibiotic that would improve the therapeutic activity against bacterial biofilms. Tobramycin was chemically conjugated with polyethylene glycol (PEG) via site-specific conjugation to form PEGylated-tobramycin (Tob-PEG). The antibacterial efficacy of Tob-PEG, as compared to tobramycin, was assessed on the planktonic phase and biofilms phase of Pseudomonas aeruginosa. The minimum inhibitory concentration (MIC80) of Tob-PEG was higher (13.9 μmol/L) than that of tobramycin (1.4 μmol/L) in the planktonic phases. In contrast, the Tob-PEG was approximately 3.2-fold more effective in eliminating bacterial biofilms than tobramycin. Specifically, Tob-PEG had a MIC80 lower than those exhibited by tobramycin (27.8 μmol/L vs 89.8 μmol/L). Both confocal laser scanning microscopy and scanning electron microscopy further confirmed these data. Thus, modification of antimicrobials by PEGylation appears to be a promising approach for overcoming the bacterial resistance in the established biofilms of Pseudomonas aeruginosa.

References

Apr 1, 1985·Antimicrobial Agents and Chemotherapy·J C NickelJ W Costerton
Sep 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L SaimanA Prince
Nov 1, 1996·Antimicrobial Agents and Chemotherapy·P S Stewart
Jun 13, 1998·Antimicrobial Agents and Chemotherapy·M E KlepserM A Pfaller
Apr 2, 1999·Antimicrobial Agents and Chemotherapy·M P Mingeot-LeclercqP M Tulkens
May 21, 1999·Science·J W CostertonE P Greenberg
Dec 3, 1999·Antimicrobial Agents and Chemotherapy·S Westbrock-WadmanC K Stover
Nov 18, 2000·Antimicrobial Agents and Chemotherapy·L P KotraS Mobashery
Feb 13, 2001·Trends in Microbiology·T F Mah, G A O'Toole
Feb 28, 2001·Microbes and Infection·N HøibyA Kharazmi
Jul 21, 2001·Lancet·P S Stewart, J W Costerton
Dec 10, 2003·Journal of Biomaterials Science. Polymer Edition·Hu Yang, Stephanie T Lopina
Jan 24, 2004·The European Respiratory Journal·R C Boucher
Jan 11, 2005·Trends in Microbiology·C A FuxP Stoodley
Feb 11, 2005·Chemical Reviews·Sophie Magnet, John S Blanchard
Mar 24, 2005·Infection and Immunity·Nadine HoffmannNiels Høiby
Jan 5, 2006·Applied Microbiology and Biotechnology·S Jana, J K Deb
Feb 3, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·N MesarosF Van Bambeke
Mar 30, 2007·Pharmaceutical Research·Lilian E van VlerkenMansoor M Amiji
Jan 22, 2008·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·J LutenW E Hennink
Mar 25, 2008·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Helle Krogh JohansenNiels Høiby
Jul 30, 2008·Journal of the American Chemical Society·Zhuang LiuHongjie Dai
Jan 10, 2009·Advanced Drug Delivery Reviews·Samuel K LaiJustin Hanes
Jan 20, 2009·The Journal of Pediatrics·Richard B Moss
Jan 29, 2009·International Journal of Biological Sciences·San TinMeena K Sakharkar
Apr 28, 2009·Respiratory Care·Felix A Ratjen
May 7, 2009·Pediatric Pulmonology·Thomas BjarnsholtNiels Høiby
Jul 28, 2009·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Barbara VuElena P Ivanova
Aug 14, 2009·FEMS Microbiology Letters·Anthony M GeorgePeter G Middleton
Dec 8, 2009·Journal of Pharmaceutical Sciences·Ibrahim M El-SherbinyHugh D C Smyth
Feb 13, 2010·International Journal of Antimicrobial Agents·Niels HøibyOana Ciofu
Apr 27, 2010·BMC Microbiology·H M H N BandaraL P Samaranayake
Jun 26, 2010·Journal of Medical Microbiology·H M H N BandaraL P Samaranayake

❮ Previous
Next ❯

Citations

Jan 6, 2016·Scientific Reports·Haibo MuJinyou Duan
Aug 19, 2015·Bioconjugate Chemistry·Martin SchmidtJoerg C Tiller
May 10, 2017·ACS Applied Materials & Interfaces·Qianqian GuoChaoxing Li
Jul 25, 2017·Applied and Environmental Microbiology·Azeza FalghoushDouglas R Call
Mar 7, 2019·Journal of Materials Science. Materials in Medicine·Qianqian GuoXiangchun Shen
May 31, 2019·AAPS PharmSciTech·Frederic TewesHugh D C Smyth
Apr 24, 2020·Advanced Healthcare Materials·Stine Egebro BirkAnja Boisen
Jan 24, 2020·Applied Microbiology and Biotechnology·Fazlurrahman KhanYoung-Mog Kim
Jan 3, 2018·Pharmaceutical Research·Tania Bahamondez-Canas, Hugh D C Smyth
Jun 6, 2017·Nanoscale·Jacob Witten, Katharina Ribbeck
Jan 4, 2018·Chemical Society Reviews·Nishad Thamban Chandrika, Sylvie Garneau-Tsodikova
Jan 26, 2021·European Journal of Medicinal Chemistry·Valentina SalaAlessandra Ghigo
Apr 21, 2018·Current Opinion in Biotechnology·Jacob WittenKatharina Ribbeck
Jun 6, 2021·International Journal of Pharmaceutics·Li DingZhengrong Cui
Mar 14, 2019·Microbial Pathogenesis·Leonardo Quintana Soares LopesRoberto Christ Vianna Santos
Aug 18, 2017·Bioconjugate Chemistry·Martin SchmidtJoerg C Tiller
Sep 17, 2020·ACS Applied Materials & Interfaces·Valerie Ortiz-GómezEduardo Nicolau

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

La Nouvelle presse médicale
J Fleurette, J P Flandrois
Canadian Journal of Public Health = Revue Canadienne De Santé Publique
M A Athar, E Knez
Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme
Y KoderaY Inada
© 2021 Meta ULC. All rights reserved